4//SEC Filing
NEOGENOMICS INC 4
Accession 0001209191-16-122335
$NEOCIK 0001077183operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 9:56 PM ET
Size
12.3 KB
Accession
0001209191-16-122335
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2016-05-18$4.78/sh+18,000$86,040→ 22,500 total - Sale
Common Stock
2016-05-18$8.50/sh−18,000$153,000→ 4,500 total - Exercise of In-Money
Stock Option (Right to buy)
2016-05-18$4.78/sh−18,000$86,040→ 67,000 totalExercise: $4.78From: 2016-05-06Exp: 2020-05-06→ Common Stock (18,000 underlying)
Holdings
- 4,500
Common Stock
- 40,000
Stock option (Right to buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (40,000 underlying) - 37,500
Stock Option (Right to buy)
Exercise: $3.93From: 2014-04-22Exp: 2018-04-22→ Common Stock (37,500 underlying)
Footnotes (3)
- [F1]On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On April 22, 2013, Mr. Ross was granted 150,000 options to purchase common stock of the Company. These options vest ratably on each of the next four anniversary dates of the grant date. On April 29, 2016, Mr. Ross exercised 112,500 of these options leaving a balance of 37,500.
- [F3]On May 6, 2015, Mr. Ross was granted 100,000 stock options to purchase common stock of the Company. These options vest ratably on each of the first three anniversary dates of the grant date. On May 9, 2016, Mr. Ross exercised 15,000 of these options and on May 18, 2016 Mr. Ross exercised 18,000 options leaving a balance of 67,000 options.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001077183
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 9:56 PM ET
- Size
- 12.3 KB